2. Mergers and acquisitions are picking up: So far this year, buyouts have boosted several biotech stocks. Some standouts: ...

Operator: Thank you for holding. We look forward to talking with you soon. Hold the line, and we will be right back with you.

iShares Biotechnology ETF (IBB) offers targeted exposure to the U.S. biotechnology sector, providing investors with access to ...

The ASX biotech sector ran strongly in October, but the big-cap thoroughbreds found the track conditions more challenging.

For Novo, it marks the boldest move yet for recently appointed CEO Maziar Mike Doustdar. In response to a slowdown in sales ...

PBS Biotech, ("PBS"), a leading provider of innovative single-use bioreactor systems and bioprocess development services, today announced the appointment of Martin Simonetti as Chief Executive Officer ...

TScan Therapeutics is laying off 30% of its workforce as the T-cell receptor (TCR) therapy biotech abandons a phase 1 solid ...

A company’s plan to edit the genomes of human embryos worries some researchers — but it might reflect the changing attitudes towards the controversial approach.

Hyderabad: Vaccine maker Bharat Biotech is foraying into the contract research development and manufacturing organisation ...

Bharat Biotech is venturing into advanced therapies by launching Nucelion Therapeutics, a subsidiary focused on cell and gene therapies. This new enti ...

Biotech Viking Therapeutics has gained prominence over the past two years, but it could have plenty of upside left.